Market Research Reports- Consulting Analysis Crystal Market Research Pharmaceutical Packaging Equipment Market | Page 2

The liquid packaging equipment segment occupied the largest share of the overall market in
2016, due to increasing demand for automation and increase in prevalence of eye and ear
disorders resulting in increased use of liquid dosage. Based on packaging type,the primary
packaging segment held the major share of the overall market in 2016, due to technological
advancements and increasing regulatory modifications related to pharmaceutical product
packaging. The aseptic filling and sealing equipment segment dominated the global primary
packaging equipment market in 2016.
North America occupied the largest share of the overall market in 2016, due to R&D expenditure
and existence of major pharmaceutical companies in this region. Asia-Pacific is poised to grow
at highest rate during the forecast period. This is attributed to factors such as increasing aging
population, rise in manufacturing activities and rapid development in Pharma and biotech
infrastructure. Moreover, the North American and European pharmaceutical companies are
outsourcing their manufacturing processes to Asian countries due to low labor cost, which is
further contributing to the market growth.
Request a sample copy of Pharmaceutical Packaging Equipment Market Research Report
@ http://www.crystalmarketresearch.com/report-sample/HC0639
Key players in the global pharmaceutical packaging equipment market includeUhlmann-Group,
Romaco Pharmatechnik GmbH, MULTIVAC, Körber AG, I.M.A. IndustriaMacchine
Automatiche S.p.A., OPTIMA packaging group GmbH, Robert Bosch Gmbh, MG2 s.r.l., Bausch
&StröbelMaschinenfabrikilshofenGmbh Co. Kg. and Marchesini Group S.p.A.
Key Findings of the Research Study:
 The liquid packaging equipment segment held the major share of the overall market in
2016, due to increase in prevalence of eye and ear disorders.
 The primary packaging segment held the major share of the overall market in 2016, due
owing to increase in need for unit dosage forms.
 North America accounted for one-third share of the global market in 2016, due to
advancements in packaging technology and rise in demand for single unit liquid doses.
 Asia-Pacific is poised to grow at highest rate during the forecast period as large number
of Pharma and biotech companies from U.S. and Europe are outsourcing their
manufacturing operations due to low labor cost.